title: Steroids withdrawal after 3 months of successful renal transplantation using a tacrolimus- and mycophenolate-based immunosuppression.
authors.affiliation: Servicio de Nefrologia, Hospital Universitario Son Dureta, Palma de Mallorca, Baleares, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Alarcón-Zurita
authors.forename: M A
authors.initials: MA
authors.lastname: Munar
authors.forename: P
authors.initials: P
authors.lastname: Losada
authors.forename: A
authors.initials: A
authors.lastname: Morey
authors.forename: J
authors.initials: J
authors.lastname: Martinez
authors.forename: F J
authors.initials: FJ
authors.lastname: de la Prada
authors.forename: J
authors.initials: J
authors.lastname: Marco
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D003404:Creatinine / Q000097:blood; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D018579:Patient Selection; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D044465:White People
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D003404:Creatinine; D009173:Mycophenolic Acid; D016559:Tacrolimus